Literature DB >> 11534497

Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.

K Cartwright1, N Noah, H Peltola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11534497     DOI： 10.1016/s0264-410x(01)00205-5

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  24 in total

1.  Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.

Authors:  Peter T Beernink; Arunas Leipus; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.

Authors:  Peter T Beernink; Jo Anne Welsch; Lee H Harrison; Arunas Leipus; Sheldon L Kaplan; Dan M Granoff
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

3.  Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil.

Authors:  Soraia M Cordeiro; Alan B Neves; Cássio T Ribeiro; Maya L Petersen; Edilane L Gouveia; Guilherme S Ribeiro; Tatiana S Lôbo; Joice N Reis; Kátia M Salgado; Mitermayer G Reis; Albert I Ko
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-08-06       Impact factor: 2.184

4.  Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

Authors:  Jerry C Nagaputra; Christine S Rollier; Manish Sadarangani; J Claire Hoe; Ojas Hrakesh Mehta; Gunnstein Norheim; Muhammad Saleem; Hannah Chan; Jeremy P Derrick; Ian Feavers; Andrew J Pollard; E Richard Moxon
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

5.  The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.

Authors:  Marzia Monica Giuliani; Laura Santini; Brunella Brunelli; Alessia Biolchi; Beatrice Aricò; Federica Di Marcello; Elena Cartocci; Maurizio Comanducci; Vega Masignani; Luisa Lozzi; Silvana Savino; Maria Scarselli; Rino Rappuoli; Mariagrazia Pizza
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

Review 7.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

8.  Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.

Authors:  K L Seib; D Serruto; F Oriente; I Delany; J Adu-Bobie; D Veggi; B Aricò; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

9.  Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form.

Authors:  Thomas A Luijkx; Harry van Dijken; Hendrik-Jan Hamstra; Betsy Kuipers; Peter van der Ley; Loek van Alphen; Germie van den Dobbelsteen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies.

Authors:  Victor C Hou; Gregory R Moe; Zyde Raad; Tomi Wuorimaa; Dan M Granoff
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.